Tietze's Syndrome

This PatientPlus article is written for healthcare professionals so the language may be more technical than the condition leaflets. You may find the abbreviations list helpful.

First described by Alexander Tietze in 1921,1,2 Tietze's syndrome has been defined as a benign, painful, non-suppurative localised swelling of the costosternal, sternoclavicular or costochondral joints, most often involving the area of the second and third ribs. Only one area is usually involved and young adults are more commonly affected.3 The syndrome is uncommon and self-limiting. The cause of Tietze's syndrome is unknown, but preceding upper respiratory infections and excessive coughing have been described in some patients.

Epidemiology

  • Tietze's syndrome can present at any age but is most common in those aged 20 to 30 years.
  • Tietze's syndrome is twice as frequent in men as in women.

Presentation

  • May be acute or gradual onset. The patient complains of pain that is often localised to the costal cartilage.
  • The syndrome usually affects the upper ribs, especially the second or third ribs.
  • The pain is aggravated by physical activity, movement, coughing or sneezing.
  • There is localised tenderness.
  • Although the pain usually disappears spontaneously, the swelling may persist long after the tenderness has disappeared.

Differential diagnosis

  • Other causes of chest pain: the pain may be confused with that of myocardial infarction and is usually unilateral on the left side.
  • Tietze's syndrome and costochondritis are not completely synonymous, as Tietze's syndrome is more localised and includes costochondral cartilage swelling, whereas costochondritis tends to be more diffuse and does not cause costochondral cartilage swelling.

Investigations

  • Diagnosis can usually be made by careful history and examination.
  • Investigations may be required to rule out other possible causes of chest pain.
  • ECG to exclude cardiovascular conditions.
  • Chest X-ray to exclude other pathologies.
  • Ultrasound may have a role in assessment and diagnosis.4
  • Magnetic resonance imaging (MRI) may also be useful and effective for some patients.5

Management

Prognosis

  • The pain usually subsides within a few weeks, with some residual swelling persisting for longer periods of time.
  • However, the course of the disease varies from spontaneous remission to persistent symptoms over years.

Document references

  1. Tietze A, Uber eine eigenartige Haufung von Fallen mit Dystrophie der Rippenknorpel. Berliner klinische Wochenschrift, 1921, 58: 829-831.
  2. Tietze's syndrome - www.whonamedit.com
  3. Aeschlimann A, Kahn MF; Tietze's syndrome: a critical review. Clin Exp Rheumatol. 1990 Jul-Aug;8(4):407-12. [abstract]
  4. Kamel M, Kotob H; Ultrasonographic assessment of local steroid injection in Tietze's syndrome. Br J Rheumatol. 1997 May;36(5):547-50. [abstract]
  5. Volterrani L, Mazzei MA, Giordano N, et al; Magnetic resonance imaging in Tietze's syndrome. Clin Exp Rheumatol. 2008 Sep-Oct;26(5):848-53. [abstract]

Acknowledgements

EMIS is grateful to Dr Colin Tidy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
Document ID: 2872
Document Version: 21
Document Reference: bgp1294
Last Updated: 29 Sep 2009
Provide feedback